Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024)
Sensus Healthcare's (SRTS) quarterly Interest & Investment Income came in at $279000.0 in Q3 2024, up 0.72% year-on-year from $277000.0 in Q4 2023, and up 33.49% quarter-over-quarter from $209000.0 in Q2 2024.
Sensus Healthcare (SRTS) Interest & Investment Income (2016 - 2024) Analysis & Trends
Sensus Healthcare's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $279000.0 for Q3 2024.
- On a quarterly basis, Interest & Investment Income rose 0.72% year-over-year to $279000.0 in Q3 2024; TTM through Sep 2024 was $979000.0, a 2.1% decrease from a year earlier, with the FY2022 full-year figure at $382000.0, up 19000.0% from the prior year.
- Interest & Investment Income rose to $279000.0 in Q3 2024 per SRTS's latest filing, from $209000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $279000.0 in Q3 2024 and bottomed at $1000.0 in Q4 2021.
- The 5-year median for Interest & Investment Income is $164000.0 (2022), against an average of $136714.3.
- Across the five-year window, Interest & Investment Income slumped 97.32% in 2020 and surged 24200.0% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $2000.0 in 2020, then sank by 50.0% to $1000.0 in 2021, then surged by 23400.0% to $235000.0 in 2022, then advanced by 17.87% to $277000.0 in 2023, then grew by 0.72% to $279000.0 in 2024.
- Per Business Quant, the three latest SRTS Interest & Investment Income figures stand at $279000.0 (Q3 2024), $209000.0 (Q2 2024), and $214000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Sensus Healthcare | 49.55 Mn | 31.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 279,000.00 |
| Jun 30, 2024 | 209,000.00 |
| Mar 31, 2024 | 214,000.00 |
| Sep 30, 2023 | 277,000.00 |
| Jun 30, 2023 | 245,000.00 |
| Mar 31, 2023 | 243,000.00 |
| Dec 31, 2022 | 235,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 50,000.00 |
| Dec 31, 2019 | 54,712.00 |
| Sep 30, 2019 | 74,736.00 |
| Jun 30, 2019 | 66,825.00 |
| Mar 31, 2019 | 72,019.00 |
| Dec 31, 2018 | 70,658.00 |
| Sep 30, 2018 | 23,010.00 |